PET scan to detect brain inflammation in autoimmune encephalitis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial uses a special PET scan (with a tracer called [18F]-DPA-714) to see if it can measure inflammation in the brain caused by autoimmune encephalitis. The goal is to see if this scan can help doctors diagnose and monitor the condition more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with possible autoimmune encephalitis and have antibodies found in your blood
- You were diagnosed within the last 6 months
- You have not received second-line immunosuppressive treatment (such as stronger medications beyond first-line steroids)
- You have a high or mixed TSPO binding affinity (determined by a genetic test)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called efgartigimod to treat autoimmune encephalitis (AIE)—a rare condition where the immune system attacks the brain. The study enrolls children 12+ and adults to see if this drug can reduce symptoms and help recovery.
This study uses a special brain scan (FDG-PET) to better understand autoimmune encephalitis, a condition where the immune system attacks the brain. It may help doctors improve diagnosis by comparing PET scan results with other tests you already had.
This study uses a special PET/MR scan to look at inflammation in the brain. It may help people with certain brain conditions like memory loss, movement problems, or autoimmune encephalitis find better treatments.
This study looks at how autoimmune encephalitis affects brain metabolism using a special PET scan. It aims to better understand the condition in people who were recently diagnosed.
This study uses a special kind of PET/MRI scan to look at inflammation in the brain and spinal cord. It may help people with conditions like stroke, multiple sclerosis, or other immune-related brain diseases.
This early-stage study tests an imaging medicine ([F-18]DPA-714) that can help researchers see inflammation in the brain and nervous system. It may help doctors better understand how “inflammation signals” differ across conditions like multiple sclerosis, fibromyalgia, and chronic fatigue syndrome.
Hear when a new Autoimmune Encephalitis (AE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.